DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dantrium (Dantrolene) - Drug Ineffective - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Drug Ineffective (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dantrium (Dantrolene) where reactions include drug ineffective. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Dantrium side effects in female

Reported by a consumer/non-health professional from Netherlands on 2012-04-17

Patient: female, weighing 48.4 kg (106.5 pounds)

Reactions: Drug Ineffective, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dantrium
    Dosage: 20 mg, bid
    Indication: Neuroleptic Malignant Syndrome
    Start date: 2011-12-30
    End date: 2012-01-05

Dantrium
    Dosage: 25 mg, tid
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-08

Dantrium
    Dosage: 20 mg, qd
    Start date: 2012-01-08
    End date: 2012-01-08

Dantrium
    Dosage: 20 mg, tid
    Start date: 2012-01-10
    End date: 2012-01-10

Dantrium
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-02

Dantrium
    Dosage: 20 mg, bid
    Start date: 2012-01-09
    End date: 2012-01-09

Other drugs received by patient: Phenobarbital TAB; Cefoperazone Sodium; Trihexyphenidyl HCL; Silece; Risperdal; Transfusion



Possible Dantrium side effects in female

Reported by a consumer/non-health professional from Netherlands on 2012-03-23

Patient: female, weighing 48.4 kg (106.5 pounds)

Reactions: Drug Ineffective, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dantrium
    Dosage: 20 mg, bid
    Start date: 2012-01-09
    End date: 2012-01-09

Dantrium
    Dosage: 20 mg, qd
    Start date: 2012-01-08
    End date: 2012-01-08

Dantrium
    Dosage: 20 mg, tid
    Start date: 2012-01-10
    End date: 2012-01-10

Dantrium
    Dosage: 25 mg, qd
    Administration route: Oral
    Start date: 2012-01-02
    End date: 2012-01-02

Dantrium
    Dosage: 20 mg, bid
    Indication: Neuroleptic Malignant Syndrome
    Start date: 2011-12-30
    End date: 2012-01-05

Dantrium
    Dosage: 25 mg, tid
    Administration route: Oral
    Start date: 2012-01-06
    End date: 2012-01-08

Other drugs received by patient: Trihexyphenidyl HCL; Silece; Cefoperazone Sodium; Risperdal; Phenobarbital TAB; Transfusion



Possible Dantrium side effects in 34 year old female

Reported by a consumer/non-health professional from Netherlands on 2012-02-21

Patient: 34 year old female

Reactions: Drug Ineffective, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dantrium
    Dosage: 20 mg, bid
    Indication: Neuroleptic Malignant Syndrome
    Start date: 2011-12-30
    End date: 2012-01-07

Dantrium
    Dosage: unk
    Administration route: Oral
    Start date: 2012-01-07
    End date: 2012-01-08

Dantrium
    Dosage: 20 mg, bid
    Start date: 2012-01-08
    End date: 2012-01-09

Other drugs received by patient: Cefoperazone Sodium; Risperdal

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017